ALVEOLAR SOFT PART SARCOMA
Clinical trials for ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a daily pill called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. The drug works by blocking signals that help tumors grow and form blood vessel…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Desperate cancer patient gets custom immune cells in last-resort trial
Disease control OngoingThis study treats one person with advanced alveolar soft part sarcoma, a rare cancer that has spread and has no standard cure. The therapy uses the patient's own immune cells, modified to recognize and attack cancer cells that carry a protein called GPNMB. The goal is to see if t…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: EARLY_PHASE1 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New combo therapy shows promise for rare sarcomas
Disease control OngoingThis study tests whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before surgery. About 140 patients with newly diagnosed, removable tumors took part. The goal is to see if the combination is safe and improves tumor respo…
Matched conditions: ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC